10-Q: The Joint Corp. Reports Mixed Q2 Results Amid Strategic Re-franchising Efforts
Quarterly Report
The Joint Corp. reported a net loss for the second quarter of 2024, while continuing its strategic shift towards re-franchising company-owned clinics.
Summary
- The Joint Corp. reported a net loss of $3.6 million for the second quarter of 2024, compared to a net loss of $0.3 million in the same period last year.
- Total revenue increased by 3.3% to $30.3 million, driven by growth in franchise operations, but offset by a slight decrease in revenue from company-owned clinics.
- The company is actively re-franchising its corporate-owned clinics, with 76% of the portfolio identified for sale.
- System-wide comparable sales increased by 2%, while mature clinics open for 48 months or more saw a decrease of 4%.
- The company repurchased regional development rights in Maryland for $0.6 million, recognizing a $0.5 million expense after netting out an existing liability.
- The company's adjusted EBITDA was $2.1 million for the quarter, compared to $3.2 million in the same period last year.
Sentiment
Score: 4
Explanation: The document presents mixed results with a net loss and decreased EBITDA, but also highlights strategic initiatives and revenue growth. The re-franchising strategy introduces uncertainty, and the company faces several risks, leading to a somewhat negative sentiment.
Positives
- Total revenue increased by 3.3% year-over-year, indicating continued growth.
- The company's franchise operations continue to expand, with 829 franchised clinics in operation.
- The company is actively pursuing a strategic re-franchising plan, which could lead to long-term growth.
- The company has $17.5 million in cash and $20 million available under its line of credit.
Negatives
- The company reported a net loss of $3.6 million for the quarter, a significant increase from the $0.3 million loss in the same period last year.
- Mature clinics open for 48 months or more saw a decrease of 4% in comparable sales.
- The company incurred $1.5 million in litigation expenses related to employment matters.
- The company's adjusted EBITDA decreased to $2.1 million from $3.2 million in the prior year period.
Risks
- The company faces risks from unfavorable global economic and political conditions, including the Ukraine War and the Israel-Gaza conflict.
- Labor shortages and inflation are impacting the company's operations, particularly labor costs.
- Increased interest rates may reduce consumer spending on the company's services.
- The company's re-franchising strategy may not be successful if franchisees cannot secure appropriate sites or attract patients.
- The company has previously identified material weaknesses in its internal controls over financial reporting.
- The company is subject to risks related to short-selling strategies and negative opinions posted on the internet.
Future Outlook
The company expects to use or redeploy cash resources to support the business within the context of prevailing market conditions, which could rapidly and materially deteriorate or otherwise change. The company believes that its existing cash and cash equivalents, anticipated cash flows from operations, and amounts available under its line of credit will be sufficient to fund its anticipated operating and investment needs for at least the next 12 months.
Management Comments
- The company seeks to be the leading provider of chiropractic care in the markets it serves and to become the most recognized brand in the industry.
- The company believes that its refined strategy to re-franchise company-owned clinics will leverage its greatest strength to drive long-term growth.
- The company believes that it continues to have a sound business concept and will benefit from the fundamental changes taking place in the manner in which Americans access chiropractic care.
- The company anticipates that 2024 will continue to be a volatile macroeconomic environment.
Industry Context
The Joint Corp. operates in the competitive chiropractic industry, facing competition from well-established independent competitors. The company's shift towards a franchise model aligns with broader trends in the healthcare industry, where franchising is increasingly used to expand service reach. The company's focus on affordable, natural solutions for wellness also reflects a growing consumer interest in alternative healthcare options.
Comparison to Industry Standards
- The Joint Corp.'s comparable sales growth of 2% is below the average growth rate for some franchise businesses in the health and wellness sector, which can range from 3% to 7% depending on the specific segment and economic conditions.
- The company's adjusted EBITDA margin of approximately 7% is lower than some mature franchise businesses in the healthcare sector, which can achieve margins of 15% to 20%.
- The company's net loss of $3.6 million contrasts with some of its competitors who are profitable, indicating that the company's re-franchising strategy is still in its early stages and has not yet resulted in improved profitability.
- Compared to companies like Massage Envy or Anytime Fitness, which have a more established franchise network, The Joint Corp. is still in a growth phase, which is reflected in its lower profitability and higher operating expenses.
- The company's focus on a cash-based model is a differentiator compared to traditional chiropractic practices that rely on insurance reimbursements, which can be a competitive advantage in terms of pricing and patient access.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | Jefferson Gramm | 2024-01-02 | Appointment to the Board of Directors |
Legal Proceedings
- The company incurred $1.5 million in litigation expenses, including settlement costs related to employment matters, during the quarter.
Related Party Transactions
- The company sold franchise licenses to family members and a co-partner of a board member, Jefferson Gramm, on terms no less favorable than those that would have been obtained in the absence of such affiliation.
Stakeholder Impact
- Shareholders may be concerned about the net loss and decreased EBITDA, but may be encouraged by the strategic re-franchising plan.
- Franchisees may benefit from the re-franchising of company-owned clinics, providing opportunities for expansion.
- Employees may be affected by the company's response to labor shortages and wage increases.
- Customers may experience changes in service as the company transitions to a more franchise-focused model.
Next Steps
- The company will continue to execute its re-franchising strategy.
- The company will focus on reinvesting in the brand, IT platforms, and potentially repurchasing regional developer territories or initiating a stock repurchase program.
- The company will continue to monitor and respond to macroeconomic conditions and their impact on the business.
Key Dates
| Date | Description |
|---|---|
| 2020-02-28 | Initial Credit Agreement date. |
| 2022-02-28 | Amendment to Credit Facilities (2022 Credit Facility). |
| 2023-05-22 | Date of Asset and Franchise Purchase Agreement for California clinics. |
| 2024-01-17 | Company paid down $2,000,000 on its Debt under the Credit Agreement. |
| 2024-03-05 | Date of special restricted stock award to certain executive employees. |
| 2024-06-24 | Date of agreement to repurchase franchise development rights in Maryland. |
| 2024-06-30 | End of the quarterly period. |
| 2024-08-01 | Date of outstanding shares count. |
| 2024-08-08 | Date of report filing. |
Keywords
chiropractic, franchise, clinics, re-franchising, revenue, EBITDA, net loss, comparable sales, regional development, healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.